Company Filing History:
1 out of 33 
1 out of 1,745 
1 out of 321 
Years Active: 2022
Title: Inventor Sébastien Maury: Innovating in Hematologic Malignancy Treatment
Introduction
Sébastien Maury, based in Joinville le Pont, France, stands out as a notable inventor in the field of medical research. His groundbreaking work focuses on the prevention and treatment of hematologic malignancy relapse, an area critical to enhancing patient outcomes after allogeneic hematopoietic stem cell transplantation.
Latest Patents
Sébastien Maury holds a significant patent entitled "Prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist." This invention pertains to the use of a TNFR2 antagonist, specifically an anti-TNFR2 antibody, for the in vivo prevention or treatment of relapse in patients who have undergone allogeneic hematopoietic stem cell transplantation or have received treatment with lymphocytes. Additionally, the patent discusses enhancing the graft-versus-leukemia activity associated with hematopoietic stem cell transplantation or lymphocyte treatments.
Career Highlights
Throughout his career, Sébastien has been affiliated with respected institutions such as Université Paris-Est Créteil Val de Marne and the Institut National de la Santé et de la Recherche Médicale. His contributions to the medical research community are evident through his focus on innovative treatments that address the challenges faced by patients with hematologic malignancies.
Collaborations
During his professional journey, Sébastien Maury has collaborated with esteemed colleagues, including José Cohen and Benoît Salomon. These collaborations have been instrumental in furthering research and development in hematology, particularly concerning innovative strategies to improve patient treatment protocols.
Conclusion
Sébastien Maury's contributions to the field of hematologic malignancy treatment exemplify the impact of innovation in medical research. His patent for the prevention and treatment of relapse showcases a significant advancement in patient care following stem cell transplantation. Through dedicated collaboration and a commitment to healthcare advancements, Maury continues to inspire progress in the field.